 |
인쇄하기
취소
|
KFDA to delay final decision of IPA safety
It will take time to decide the safety of isopropylantipyrine (IPA), a substance used to kill pain.
The Korea Food and Drug Administration’s Central Pharmaceutical Deliberation Committee will finally assess the IPA safety issues after careful review of IPA related adverse events and usage in foreign countries.
No new safety concerns are raised by a review of adverse events reported in peo...
The Korea Food and Drug Administration’s Central Pharmaceutical Deliberation Committee will finally assess the IPA safety issues after careful review of IPA related adverse events and usage in foreign countries.
No new safety concerns are raised by a review of adverse events reported in peo...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.